Bick et al., 2015 - Google Patents
The string sign for diagnosis of mucinous pancreatic cystsBick et al., 2015
- Document ID
- 4918538837011106269
- Author
- Bick B
- Enders F
- Levy M
- Zhang L
- Henry M
- Dayyeh B
- Chari S
- Clain J
- Farnell M
- Gleeson F
- Kendrick M
- Pearson R
- Petersen B
- Rajan E
- Vege S
- Topazian M
- Publication year
- Publication venue
- Endoscopy
External Links
Snippet
Background and study aims: Pancreas cyst fluid analysis does not provide optimal discrimination between mucinous and nonmucinous cysts. The aim of this study was to assess the performance characteristics of the “string sign”–a test performed at the time of …
- 238000003745 diagnosis 0 title abstract description 34
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R31/00—Arrangements for testing electric properties; Arrangements for locating electric faults; Arrangements for electrical testing characterised by what is being tested not provided for elsewhere
- G01R31/28—Testing of electronic circuits, e.g. by signal tracer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/26—Investigating or analysing materials by specific methods not covered by the preceding groups oils; viscous liquids; paints; inks
- G01N33/28—Oils, i.e. hydrocarbon liquids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bick et al. | The string sign for diagnosis of mucinous pancreatic cysts | |
| Park et al. | Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts | |
| Chen et al. | Endoscopic ultrasound (EUS)-guided fine needle biopsy alone vs. EUS-guided fine needle aspiration with rapid onsite evaluation in pancreatic lesions: a multicenter randomized trial | |
| Khashab et al. | Should we do EUS/FNA on patients with pancreatic cysts? The incremental diagnostic yield of EUS over CT/MRI for prediction of cystic neoplasms | |
| European Study Group on Cystic Tumours of the Pancreas | European evidence-based guidelines on pancreatic cystic neoplasms | |
| DeWitt et al. | Comparison of EUS-guided tissue acquisition using two different 19-gauge core biopsy needles: a multicenter, prospective, randomized, and blinded study | |
| Scheiman et al. | American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts | |
| Puli et al. | How good is endoscopic ultrasound–guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: a meta-analysis and systematic review | |
| Williams et al. | Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience | |
| LeBlanc et al. | Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis | |
| Hwang et al. | The incidental upper gastrointestinal subepithelial mass | |
| Cai et al. | Investigation of synthetic magnetic resonance imaging applied in the evaluation of the tumor grade of bladder cancer | |
| Smith et al. | Incidentally identified common bile duct dilatation: a systematic review of evaluation, causes, and outcome | |
| Anderson et al. | Determining tissue of origin for metastatic cancers: meta-analysis and literature review of immunohistochemistry performance | |
| Mangiavillano et al. | Endoscopic ultrasound-guided fine-needle biopsy with or without macroscopic on-site evaluation: a randomized controlled noninferiority trial | |
| Xu et al. | Endoscopic ultrasound elastography for differentiation of benign and malignant pancreatic masses: a systemic review and meta-analysis | |
| Oh et al. | Endoscopic ultrasound-guided fine-needle aspiration can target right liver mass | |
| Gharibvand et al. | The role of ultrasound in diagnosis and evaluation of bladder tumors | |
| Oh et al. | Cyst fluid amylase and CEA levels in the differential diagnosis of pancreatic cysts: a single-center experience with histologically proven cysts | |
| Le Pen et al. | A health economic evaluation of needle-based confocal laser endomicroscopy for the diagnosis of pancreatic cysts | |
| Khoury et al. | The role of rapid on‐site evaluation on diagnostic accuracy of endoscopic ultrasound fine needle aspiration for pancreatic, submucosal upper gastrointestinal tract and adjacent lesions | |
| Alkaade et al. | Role of endoscopic ultrasound-guided fine-needle aspiration cytology, viscosity, and carcinoembryonic antigen in pancreatic cyst fluid | |
| Ishikawa et al. | Usefulness of macroscopic on‐site evaluation using a stereomicroscope during EUS‐FNB for diagnosing solid pancreatic lesions | |
| Waters et al. | Intraductal papillary mucinous neoplasm—when to resect? | |
| Lee et al. | Is prostate imaging reporting and data system version 2 sufficiently discovering clinically significant prostate cancer? Per-lesion radiology-pathology correlation study |